Algert Global LLC 4 D Molecular Therapeutics, Inc. Transaction History
Algert Global LLC
- $3.72 Billion
- Q3 2024
A detailed history of Algert Global LLC transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 73,436 shares of FDMT stock, worth $336,336. This represents 0.02% of its overall portfolio holdings.
Number of Shares
73,436
Previous 16,588
342.71%
Holding current value
$336,336
Previous $348,000
128.16%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding FDMT
# of Institutions
145Shares Held
56.8MCall Options Held
137KPut Options Held
111K-
Bvf Inc San Francisco, CA7.38MShares$33.8 Million2.54% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.1MShares$23.3 Million0.77% of portfolio
-
Black Rock Inc. New York, NY4.9MShares$22.4 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.4MShares$20.2 Million4.93% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.1MShares$18.8 Million1.63% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $148M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...